Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 848 participants.
Also called NCT07779746
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 848 participants
- Registry
-
NCT07779746
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07779746. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
- Acronym
- SAFE-D2
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Condition
- End Stage Kidney Disease (ESRD)
- Condition
- Dialysis Patients
- Intervention (Drug)
- Eliquis
- Intervention (Other)
- No oral anticoagulation
- Lead sponsor
- Unity Health Toronto
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct07779746- Content hash
09d6271d65605d232e78870dc0bf9473cf2dd8f570c329da5c9bd12eb578aa6e